ES2060927T3 - Anticuerpos contra la fibrina; peptidos inmunogenos adecuados para preparar los anticuerpos, metodo para determinar fibrina y preparacion farmaceutica basada en los anticuerpos. - Google Patents

Anticuerpos contra la fibrina; peptidos inmunogenos adecuados para preparar los anticuerpos, metodo para determinar fibrina y preparacion farmaceutica basada en los anticuerpos.

Info

Publication number
ES2060927T3
ES2060927T3 ES90201065T ES90201065T ES2060927T3 ES 2060927 T3 ES2060927 T3 ES 2060927T3 ES 90201065 T ES90201065 T ES 90201065T ES 90201065 T ES90201065 T ES 90201065T ES 2060927 T3 ES2060927 T3 ES 2060927T3
Authority
ES
Spain
Prior art keywords
fibrin
antibodies
pharmaceutical preparation
antibody based
determining
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90201065T
Other languages
English (en)
Inventor
Willem Nieuwenhuizen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nederlandse Organisatie voor Toegepast Natuurwetenschappelijk Onderzoek TNO
Original Assignee
Nederlandse Organisatie voor Toegepast Natuurwetenschappelijk Onderzoek TNO
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nederlandse Organisatie voor Toegepast Natuurwetenschappelijk Onderzoek TNO filed Critical Nederlandse Organisatie voor Toegepast Natuurwetenschappelijk Onderzoek TNO
Application granted granted Critical
Publication of ES2060927T3 publication Critical patent/ES2060927T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/36—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood coagulation factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6835—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
    • A61K47/6845—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a cytokine, e.g. growth factors, VEGF, TNF, a lymphokine or an interferon
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

ESTOS ANTICUERPOS ESTAN DIRIGIDOS CONTRA UNA SECUENCIA DE AMINO ACIDOS QUE CORRESPONDEN A LA SECUENCIA 311-379, EN PARTICULAR LA 311-336 DE LA CADENA DE FIBRINOGENO, LOS ANTICUERPOS REACCIONAN ESPECIFICAMENTE CON FIBRINA TANTO DEL TIPO I COMO DEL TIPO II, Y SON MUY EFECTIVOS PARA DETECTAR, PREVENIR Y TRATAR LA FORMACION DE COAGULOS DE SANGRE.
ES90201065T 1989-05-01 1990-04-26 Anticuerpos contra la fibrina; peptidos inmunogenos adecuados para preparar los anticuerpos, metodo para determinar fibrina y preparacion farmaceutica basada en los anticuerpos. Expired - Lifetime ES2060927T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL8901102A NL8901102A (nl) 1989-05-01 1989-05-01 Antilichamen tegen fibrine; voor de bereiding van de antilichamen geschikte immunogene peptiden, werkwijze voor het bepalen van fibrine en farmaceutisch preparaat op basis van de antilichamen.

Publications (1)

Publication Number Publication Date
ES2060927T3 true ES2060927T3 (es) 1994-12-01

Family

ID=19854590

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90201065T Expired - Lifetime ES2060927T3 (es) 1989-05-01 1990-04-26 Anticuerpos contra la fibrina; peptidos inmunogenos adecuados para preparar los anticuerpos, metodo para determinar fibrina y preparacion farmaceutica basada en los anticuerpos.

Country Status (8)

Country Link
US (1) US5124439A (es)
EP (1) EP0396188B1 (es)
JP (1) JP2634683B2 (es)
AT (1) ATE108833T1 (es)
DE (1) DE69010750T2 (es)
DK (1) DK0396188T3 (es)
ES (1) ES2060927T3 (es)
NL (1) NL8901102A (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994009034A1 (en) * 1992-10-12 1994-04-28 Agen Limited Clot directed anticoagulant, process for making same and methods of use
EP0678524B1 (en) * 1993-11-02 2008-02-06 Mitsubishi Kagaku Iatron, Inc. Anti-human soluble fibrin antibodies, hybridoma producing them, and immunoassaying method
CA2188647A1 (en) * 1994-05-02 1995-11-09 Stewart Anthony Cederholm-Williams Recombinant fibrin chains, fibrin and fibrin-homologs
DE19729591A1 (de) * 1997-07-10 1999-02-11 Therasorb Medizinische Systeme Mittel zur Behandlung und/oder Prophylaxe von Mikrozirkulationsstörungen
US9814672B2 (en) 2007-03-09 2017-11-14 Susan T. Laing Echogenic vehicle for clinical delivery of plasminogen activator and other fibrin-binding therapeutics to thrombi

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4916070A (en) * 1986-04-14 1990-04-10 The General Hospital Corporation Fibrin-specific antibodies and method of screening for the antibodies
DE3701812A1 (de) * 1987-01-22 1988-08-04 Max Planck Gesellschaft Fibrinspezifischer antikoerper, verfahren zur seiner herstellung und seine verwendung

Also Published As

Publication number Publication date
US5124439A (en) 1992-06-23
DE69010750T2 (de) 1994-12-22
EP0396188B1 (en) 1994-07-20
ATE108833T1 (de) 1994-08-15
NL8901102A (nl) 1990-12-03
JP2634683B2 (ja) 1997-07-30
DK0396188T3 (da) 1994-08-22
DE69010750D1 (de) 1994-08-25
EP0396188A1 (en) 1990-11-07
JPH0348159A (ja) 1991-03-01

Similar Documents

Publication Publication Date Title
AR008680A1 (es) Substitutos de plaquetas y metodos de conjugacion apropiados para su preparacion
DK152082A (da) Anvendelse af radiomaerket peptid afledt af tvaerbundet fibrin til at lokalisere blodpropper in vivo
EA199800946A1 (ru) Концентрированный препарат антител
DE68924162D1 (de) Stressproteine und verwendungen dafür.
AR058982A1 (es) Vector de expresion de la proteina bicunina y metodo para producir dicha proteina
DK215287A (da) Dna-sekvenser, der koder for et protein med angiogen virkning, vektorer, vaertsceller og fremgangsmaader til udtrykkelse af proteinet, samt laegemidler indeholdende dette
EA200000449A1 (ru) Модифицированные витамины к-зависимые полипептиды
DK0654078T3 (da) Thrombinblodfraktion til anvendelse i en medicinsk procedure
ES8800267A1 (es) Un metodo para obtener un peptido biologicamente activo que tiene afinidad para un ligando proteinaceo o su receptor
DE3382837D1 (de) Herstellung von funktionellen, menschlichen Urokinaseproteinen
ES8800347A1 (es) Metodo para preparar uroquinasa de una sola cadena resistente a proteasas
ES2196031T3 (es) Derivados peptidicos terapeutico.
DK614987A (da) Syntetiske htlv-iii peptider, praeparater og anvendelser deraf
ES550943A0 (es) Un procedimiento para preparar una proteina de fusion derivada de la secuencia de aminoacidos de la preprorrelaxina humana.
ES552093A0 (es) Un procedimiento para sintetizar una secuencia de aminoacidos que contienen la totalidad o parte de la secuencia de aminoacidos de la preprorrelaxina -h2 humana.
ES2037669T3 (es) Un procedimiento para preparar una sustancia que se une a la trombina.
ES2047014T3 (es) Procedimiento para preparar un catalizador basado en plata y procedimiento para epoxidar olefinas superiores.
DK0770680T3 (da) Antistoffer mod lymfocyt-associeret celleoverfladeprotein
ATA91797A (de) Eine das vwf-propeptid enthaltende pharmazeutische präparation
DE69534180D1 (de) Promotor der tie rezeptor protein kinase
ES2060927T3 (es) Anticuerpos contra la fibrina; peptidos inmunogenos adecuados para preparar los anticuerpos, metodo para determinar fibrina y preparacion farmaceutica basada en los anticuerpos.
IT8448540A0 (it) Proteine umane, antisieri per esse, procedimento per prepararli e corredi di prova che li contengono
ES2038969T3 (es) Procedimiento para la renaturalizacion de proteinas.
ES2056149T3 (es) Ambliommina, una nueva sustancia activa para la terapia anticoagulante.
ES2077674T3 (es) Aumento de la produccion de proteinas en animales.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 396188

Country of ref document: ES